1996
DOI: 10.1007/bf01690507
|View full text |Cite
|
Sign up to set email alerts
|

Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

10
76
4
7

Year Published

2001
2001
2015
2015

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 115 publications
(97 citation statements)
references
References 18 publications
10
76
4
7
Order By: Relevance
“…In bloodstream infections, the breakpoints or MICs of antifungal agents must be determined to identify risk factors for infections by resistant yeasts and to assess the clinical relevance of the treatments. Similar reports in Europe have shown that bloodstream infections caused by yeasts are increasing [11][12][13].…”
Section: Introductionsupporting
confidence: 56%
“…In bloodstream infections, the breakpoints or MICs of antifungal agents must be determined to identify risk factors for infections by resistant yeasts and to assess the clinical relevance of the treatments. Similar reports in Europe have shown that bloodstream infections caused by yeasts are increasing [11][12][13].…”
Section: Introductionsupporting
confidence: 56%
“…For instance, in The Netherlands an increasing incidence of candidemia has been reported during the period between eighties and nineties (Voss et al, 1996) but on the other hand, in a neighbouring country such as Switzerland the incidence of Candida BSI infections remained unchanged during the same period (Marchetti et al, 2004). Therefore, it seems that there are some differences in the epidemiology of candidemia between different countries.…”
Section: Introductionmentioning
confidence: 99%
“…In the 1980s, Candida species were reported to be the seventh most common nosocomial pathogens hospitalwide, ranking fourth in intensive care units (ICUs) where they accounted for c. 10% of all bloodstream infections [5][6][7]. This general incidence has continued in the past decade in the USA [8], as well as in Europe [9][10][11][12]. Despite the high morbidity and mortality associated with candidosis, no decrease in the incidence of this infection has yet been achieved.…”
Section: Introductionmentioning
confidence: 99%